Clinical Trials Report Highlights Australia’s Competitive Advantages… And Weaknesses
A new report has found that Australia’s clinical trials sector is large. As international competition for clinical trials intensifies, Australian medtech trade group, MTAA, has pledged to work with industry to overcome impediments to conducting trials in the country.
You may also be interested in...
Marketing applications for 10 new drugs have been added to the latest list of products under review by the European Medicines Agency.
Applications for the accelerated assessment of planned EU marketing applications for two drugs are being considered by the European Medicines Agency.
The sponsor of an ophthalmic formulation of bevacizumab is set to speak up for its marketing authorization application during a European Medicines Agency oral explanation meeting.